Sir Mark Rowley said that Jews were facing a ‘ghastly Venn diagram’ of hate from all sides.

Scientists and tourists alike have been amazed by the massive sea lion hanging out on a San Francisco pier. The species can ...

In a video for the Virginia Chapter of Man Up To Cancer called “Gathering of Wolves”, you hear this: “That’s one of the ...

Patients with multiple myeloma (MM) have a distinct pattern of second primary malignancy (SPM), with a markedly inc ...

Karen Fancher, PharmD, BCOP, associate professor of pharmacy practice at Duquesne University and clinical oncology specialist ...

Tanya Siddiqi, MD, shares her personal experience using continuous BTK inhibitor therapy for the treatment of patients with ...

Six-year data show continuous zanubrutinib keeps CLL controlled longer than bendamustine-rituximab, including high-risk ...

A post hoc analysis evaluates zanubrutinib vs acalabrutinib-venetoclax in treatment naive chronic lymphocytic leukemia using indirect comparisons of data from two phase 3 trials.

The EMA has recommended label expansions for Inaqovi, Opdivo, and Venclyxto, broadening treatment options in AML, Hodgkin lymphoma, and CLL.

Single agent duvelisib demonstrated clinically meaningful response rates, including a substantial proportion of complete responses, in a heavily ...

Premera commercial members face loss of provider network coverage statewide. Some Regence commercial members also risk losing ...